KATRINA JONES HARRIS: Open Payments
NPI 1316491046 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,828 in 155 payments from 30 companies in 2025. Trend: 2023 $3,621 · 2024 $4,798 · 2025 $4,828
Food & beverage: $4,828
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $554 |
| Novo Nordisk Inc | 19 | $507 |
| Axsome Therapeutics, Inc. | 17 | $399 |
| AstraZeneca Pharmaceuticals LP | 14 | $382 |
| Amgen Inc. | 10 | $322 |
| Vanda Pharmaceuticals Inc. | 3 | $319 |
| PFIZER INC. | 10 | $276 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $252 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $213 |
| Otsuka America Pharmaceutical, Inc. | 2 | $208 |
Products named: FANAPT, BREZTRI, QULIPTA, XIFAXAN, Auvelity, Kerendia, REXULTI, OTEZLA.
Industry payments across AL — which companies pay providers there.
